2-(2,3-dihydro-1-benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

CAS No.：

Cat. No.: SC22194

Available on Request

Price on Request

Bulk Inquiry

Product Name :2-(2,3-dihydro-1-benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Cat. No.: :SC22194

Purity / Specification :—

CAS No. :934586-50-2

MDL No. :MFCD11109314

Molecular Formula :C₁₄H₁₉BO₃

LogP :1.92

Molecular Weight :246.11

TPSA :27.7

Category :Building Blocks

HSN Code :—

SMILES Code :CC1(C)OB(c2cccc3c2OCC3)OC1(C)C

Melting Point :—

InChI Key : :HCAAUTYLSSDHFV-UHFFFAOYSA-N

Boiling Point :No data available

Application Note

AI Generated

Generated by AI. Verify before use in regulatory documents.

Lipinski & ADMET Properties

Computational estimate

Lipinski Rule of 5

✓ PASS

MW ≤ 500 Da✓ 246.1 Da

LogP ≤ 5✓ 1.92

HBD ≤ 5✓ 0

HBA ≤ 10✓ 3

Max 1 violation allowed for oral bioavailability.

Drug-likeness Score

81/100

Good drug-like profile

Predicted LogP

1.92log units

Optimal range (0–3)

CNS Permeability

Clark model · J Pharm Sci, 1999

CNS+ likely

TPSA 27.7Å² · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−

Requires experimental confirmation.

⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.